References
- Ziel HK, Finkle WD: Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167–1170, 1975
- Smith DC, Prentice R, Thompson D, et al: Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293:1164–1167, 1975
- Kistner RW: Estrogen controversy updated. Female Patient 1:25–27, 1976
- Greenblatt R: Menopause. Ob-Gyn Digest, May 15, 1976
- Aitken JM, Hart DM, Lindsay R: Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J 3:515–518, 1973
- Lindsay R, Hart DM, Aitken JM, et al: Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1:1038–1041, 1976
- Meema S, Meema HE: Menopausal bone loss and estrogen replacement. Isr J Med Sci 12:601–606, 1976
- Johansson BW, Kaij L, Kullander S, et al: On some late effects of bilateral oophorectomy in the age range 15–30 years. Acta Obstet Gynecol Scand 54:449–461, 1975
- Ryan KR: Estrogens and atherosclerosis. Clin Obstet Gynecol 19:805–815, 1976
- Rosenberg L, Armstrong B, Jick H: Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med 294:1256–1259, 1976
- Hoover R, Gray LA Sr, Cole P, et al: Menopausal estrogens and breast cancer. N Engl J Med 295:401–405, 1976
- Burch JC, Byrd BF, Vaughn WK: Results of estrogen treatment in 1000 hysterectomized women for 14,318 years. In Campbell S (Editor): The Management of Menopause and Postmenopausal Years. Proceedings of the International Symposium Heid in London, Nov 1975. Lancaster, England, MTP Press Ltd, 1976, pp 164–169
- Arthes FG, Sartwell PE, Lewison EF: The pill, estrogens and the breast: Epidemiologic aspects. Cancer 28:1391, 1971
- Speroff L, Judd H, Richart R, et al: The estrogen replacement controversy. Contemp Ob-Gyn 8:143–178, 1976